Zhong X - Search Results

1

The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.

Dong S, Qu X, Li W, Zhong X, Li P, Yang S, Chen X, Shao M, Zhang L. Dong S, et al. Among authors: zhong x. J Hematol Oncol. 2015 Apr 29;8:43. doi: 10.1186/s13045-015-0140-6. J Hematol Oncol. 2015. PMID: 25925741 Free PMC article.

2

Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.

Zhong X, Li M, Nie B, Wu F, Zhang L, Wang E, Han Y. Zhong X, et al. Ann Surg Oncol. 2013 Mar;20(3):1044-52. doi: 10.1245/s10434-012-2377-4. Epub 2012 May 17. Ann Surg Oncol. 2013. PMID: 22592183

3

Analysis of EHMT1 expression and its correlations with clinical significance in esophageal squamous cell cancer.

Guan X, Zhong X, Men W, Gong S, Zhang L, Han Y. Guan X, et al. Among authors: zhong x. Mol Clin Oncol. 2014 Jan;2(1):76-80. doi: 10.3892/mco.2013.207. Epub 2013 Oct 24. Mol Clin Oncol. 2014. PMID: 24649311 Free PMC article.

4

Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis.

Zhong X, Guan X, Dong Q, Yang S, Liu W, Zhang L. Zhong X, et al. Tumour Biol. 2014 Jul;35(7):7155-62. doi: 10.1007/s13277-014-1935-8. Epub 2014 Apr 25. Tumour Biol. 2014. PMID: 24763826

5

Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis.

Zhong X, Chen X, Guan X, Zhang H, Ma Y, Zhang S, Wang E, Zhang L, Han Y. Zhong X, et al. Histopathology. 2015 Jan;66(2):192-200. doi: 10.1111/his.12456. Epub 2014 Nov 13. Histopathology. 2015. PMID: 24805087

6

Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer.

Zhong X, Guan X, Liu W, Zhang L. Zhong X, et al. Oncol Lett. 2014 Oct;8(4):1470-1476. doi: 10.3892/ol.2014.2396. Epub 2014 Jul 30. Oncol Lett. 2014. PMID: 25202351 Free PMC article.

7

Systematic mediastinal lymphadenectomy or mediastinal lymph node sampling in patients with pathological stage I NSCLC: a meta-analysis.

Dong S, Du J, Li W, Zhang S, Zhong X, Zhang L. Dong S, et al. Among authors: zhong x. World J Surg. 2015 Feb;39(2):410-6. doi: 10.1007/s00268-014-2804-8. World J Surg. 2015. PMID: 25277979 Review.

8

PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression.

Qu X, Liu J, Zhong X, Li X, Zhang Q. Qu X, et al. Among authors: zhong x. J Transl Med. 2015 Sep 15;13:301. doi: 10.1186/s12967-015-0666-y. J Transl Med. 2015. PMID: 26373553 Free PMC article.

9

Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer.

Qu XH, Liu JL, Zhong XW, Li XI, Zhang QG. Qu XH, et al. Among authors: zhong xw. Oncol Lett. 2015 Sep;10(3):1677-1685. doi: 10.3892/ol.2015.3457. Epub 2015 Jul 3. Oncol Lett. 2015. PMID: 26622731 Free PMC article.

10

Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.

Yang S, Dong S, Qu X, Zhong X, Zhang Q. Yang S, et al. Among authors: zhong x. Mol Med Rep. 2017 Feb;15(2):719-723. doi: 10.3892/mmr.2016.6032. Epub 2016 Dec 13. Mol Med Rep. 2017. PMID: 27959454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,526 results

Search Page

Filters